Open original FDA record ↗Recall record
- FDA identifier
- Z-2222-2015
- Company in FDA record
- EXP Pharmaceutical Services Corp
- FDA classification date
- Jul 24, 2015
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
EXP did not register as a medical device establishment, list the devices being recalled, or establish its own quality system and instead relied on the fact that its vendors were registered and had their own quality systems.
Source facts
- Action
- EXP first notified their customers to quarantine EXP devices February 11-17, 2015. Customers were contacted through telephone, e-mail, and written communications. Customers were instructed to recover and quarantine all EXP products from their inventories. EXP believes that they have contacted all customers to whom products were shipped between April 26, 2014, and December 9, 2014. A second letter is scheduled to be sent in July 2015 (date unknown at this time). This letter will advise users of the recall of due to lack of registration with the FDA.
- Initiated
- 2015-02-11
- Root cause
- Other
- Terminated
- 2015-12-30
- Distribution
- Distributed in DC and the states of CO, CA, FL, TX, and AR.
- Recall number
- Z-2222-2015
- Recall status
- Terminated
- CDRH record ID
- 138369
- FDA classified
- 2015-07-24
- Recall event number
- 71608